Characteristics and frequency of tuberculosis before and during the COVID-19 pandemic among adults treated in a primary healthcare center in Lima, Peru, 2019–2020
DOI:
https://doi.org/10.24265/horizmed.2023.v23n1.06Keywords:
tuberculosis, pandemics, COVID-19, HIVAbstract
Objective: To determine the characteristics and frequency of patients aged over 18 years with tuberculosis (TB) before (2019) and during (2020) the COVID-19 pandemic in a healthcare center (CS) in Lima, Peru. Materials and methods: A descriptive retrospective study that included medical records of 100 patients aged > 18 years enrolled in the TB program at CS Los Libertadores (SMP-Lima, Peru) from 2019 to 2020. Sociodemographic (sex, origin, age), clinical (admission/discharge status, body mass index, comorbidities, TB infection site, type of resistance, treatment regimen) and laboratory (smear microscopy, culture, drug susceptibility testing) variables were analyzed. Patients who did not have all the variables were excluded. An Excel database was prepared and a descriptive statistical analysis of the qualitative variables, expressed in frequencies, and quantitative variables, expressed in measures of central tendency (mean) and standard deviation, was performed using IBM SPSS Statistics. TB prevalence per year was determined, according to the population assigned to the healthcare center. Said information was obtained through the Tuberculosis Management Information System (SIGTB). Results: TB prevalence was 0.0015 % (49 patients) in 2019 and 0.075 % (51 patients) in 2020. In both years, the male sex and the age group between 18 and 29 years prevailed, and the most common site of infection were the lungs. In 2020, an increase in HIV comorbidity and mortality rate (0.074) was observed, as well as more positive smear microscopy cases. Conclusions: TB prevalence was higher in 2020, the first year of the COVID-19 pandemic, due to a reduced approach to TB programs as a result of the situation imposed by the pandemic. In addition, TB mortality rates raised in the same year, probably due to an increase in treatment dropouts or HIV and diabetes comorbidity rates.
Downloads
References
Organización Mundial de la Salud. En riesgo los progresos mundiales contra la tuberculosis [Internet]. Ginebra:OMS; 2020. Disponible en: https://www.who.int/es/news/item/14-10-2020-who-global-tb-progress-at-risk.
Paneque E, Rojas LY, Pérez M. La tuberculosis a través de la historia: un enemigo de la humanidad. Rev Haban Cienc Méd. 2018;17(3):353-63.
Fordham von Reyn, C. Tuberculosis: Natural history, microbiology and pathogenesis [Internet]. UpTodate; 2021. Disponible en: https://www.uptodate.com/contents/tuberculosis-natural-historymicrobiology-and-pathogenesis
Ramírez NA, Cocotle BE, Méndez A, Arenas J. Mycobacterium tuberculosis: Su pared celular y la utilidad diagnóstica de las proteínas 16 y 38 kDa. Rev Med UV. 2002;2(2):39-43.
Dorronsoro I, Torroba L. Microbiología de la tuberculosis. An Sist Sanit Navar. 2007;30(Supl. 2):67-84.
Clínic Barcelona. SARS-CoV-2 y la enfermedad COVID-19? [Internet]. Barcelona; 2020. Disponible en: https://www.clinicbarcelona.org/asistencia/enfermedades/covid-19.
Ruiz-Bravo A, Jiménez-Valera M. SARS-CoV-2 y pandemia de síndrome respiratorio agudo (COVID-19). Ars Pharm. 2020;61(2):63-79.
Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potenial impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8(9):e1132-41.
Suárez CM, Silva CM. COVID-19 y tuberculosis: El encuentro entre nuevas amenazas y viejas enfermedades. Rev Fac Med Hum. 2021;21(1):251-2.
Organización Mundial de la Salud. Informe sobre la tuberculosis en el mundo 2019 [Internet]. Ginebra:OMS; 2019. Disponible en: https://vacunasaep.org/profesionales/noticias/tbc-informe-OMS-2019.
Organización Mundial de la Salud. Tuberculosis [Internet]. Ginebra:OMS; 2021. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/tuberculosis.
World Health Organization. Global tuberculosis report 2021 [Internet]. Geneva: WHO. 2021 [citado el 14 de febrero de 2023]. Disponible en: https://www.who.int/publications-detail-redirect/9789240037021.
Organización Panamericana de la Salud. Tuberculosis en las Américas. Informe regional 2020 [Internet]. Washington DC:OMS; 2021. Disponible en: https://iris.paho.org/handle/10665.2/55047.
Organización Panamericana de la Salud. El diagnóstico de nuevos casos de tuberculosis se redujo entre un 15 y 20% durante 2020 en las Américas debido a la pandemia [Internet]. Washington DC:OMS; 2021.
Instituto Nacional de Estadística e Informática. Población con tuberculosis, según departamento, 2010-2021 [Internet]. INEI: Lima; 2020. https://www.inei.gob.pe/media/MenuRecursivo/indices_tematicos/16-tuberculosis_1.xlsx.
Brito JA, Castillo AL, León G. Pregrado. [Milagro] Universidad Estatal de Milagro; 2018.
Aguilar-León P, Cotrina-Castañeda J, Zavala-Flores E. SARS-CoV-2 infection and pulmonary tuberculosis: an analysis of the situation in Peru. Cad Saude Publica. 2020;36(11):e00094520.
Barba JR. Tuberculosis. ¿Es la pandemia ignorada? Rev Mex Patol Clin Med Lab. 2020;67(2):93-112.
Ministerio de Salud. Memoria 2016 - 2020: Dirección de Prevención y Control de Tuberculosis - DPCTB. [Internet]. Lima:MINSA; 2021.
Carranza JA, Vera BE Jaramillo E. Prevalencia de tuberculosis multidrogoresistente en pacientes diagnosticados de tuberculosis pulmonar por baciloscopia [Tesis de Título]. [Guayaquil]: Universidad de Guayaquil; 2018.
Salazar-Capcha NE. Prevalencia de la tuberculosis en la Provincia de Alto Amazonas, Loreto, Perú. Enero 2014 - Junio 2017 [Tesis de posgrado]. Trujillo: Universidad Nacional de Trujillo. Facultad de Ciencias Biológicas; 2020.
Cardenas-Escalante J, Fernandez-Saucedo J, Cubas WS. Impacto de la pandemia por COVID-19 en la tuberculosis en el Perú: ¿nos estamos olvidando de alguien? Enferm Infecc Microbiol Clin. 2022;40(1):46-7.
Organización Panamericana de la Salud. Aumenta la morbimortalidad por tuberculosis durante la pandemia de COVID-19 [Internet]. Washington DC:OMS; 2022. Disponible en: https://www.paho.org/es/noticias/27-10-2022-aumenta-morbimortalidad-por-tuberculosis-durante-pandemia-covid-19.
Adepoju P. Tuberculosis and HIV responses threatened by COVID-19. Lancet HIV. 2020;7(5):E319-20.
Vázquez-Temprano N, Ursúa-Díaz MI, Salgado-Barreira A, Vázquez-Gallardo R, Bastida VT, Anibarro L. Descenso en la incidencia de tuberculosis y pandemia COVID-19, ¿ficción o realidad? Arch Bronconeumol. 2022;58(3):272-4.
Bernal-Duran X, Cubas-Alcántara A, Narváez K, Navarro-Castro M, Villanueva-Villegas R, Llanos-Tejada F. Impact of the COVID-19 pandemic in a specialized Tuberculosis unit. Rev Fac Med Hum. 2022;22(3):650-2.
Ministerio de Salud. Minsa: INS continúa fortaleciendo servicios para combatir a la tuberculosis en el Perú [Internet]. Lima:MINSA; 2022. Disponible en: http://www.tuberculosis.minsa.gob.pe/portaldpctb/noticias/detalle_noticia.aspx?not=1119.
Centros para el Control y la Prevención de Enfermedades. Tuberculosis resistente a los medicamentos [Internet]. Atlanta:CDC; 2016. Disponible en: https://www.cdc.gov/tb/esp/topic/drtb/default.htm
Ministerio de Salud. Boletín Epidemiológico del Perú 2021 [Internet]. Lima:MINSA; 2021. Disponible en: https://www.dge.gob.pe/epipublic/uploads/boletin/boletin_20214.pdf.
Ministerio de Salud. Análisis de la Situación de Salud del distrito de SMP [Internet]. Lima:MINSA; 2019. Disponible en: https://www.dge.gob.pe/portal/docs/asis-lima-2019/CD_MINSA/DOCUMENTOS_ASIS/ASIS_SAN%20MARTIN%20DE%20PORRES%202019.pdf.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
